Stay informed with the latest updates for the inheritable blood disorders community.

Advocacy & Legislative
What's Next for the ACA?
What's Next for the ACA?
Medical
Visit Research Poster Abstracts from 72nd BDC
Visit Research Poster Abstracts from 72nd BDC
Medical
Unanswered Questions Remain in Gene Therapy
Unanswered Questions Remain in Gene Therapy
Industry
Sanofi Publishes Updates to BIVV001 Trial
Sanofi Publishes Updates to BIVV001 Trial
NBDF & Community
NHF is Charting a Course for the Future
NHF is Charting a Course for the Future
Medical
Hemophilia B Therapy to be Discontinued
Hemophilia B Therapy to be Discontinued
Medical
Genentech Provides Updates on Hemlibra Product Particles
Genentech Provides Updates on Hemlibra Product Particles
NBDF & Community
NHF's Board of Directors Meeting
NHF's October 2020 Board of Directors Meeting
NBDF & Community
NHF, HFA and Hemophilia Alliance Continue Push for Information on Stimate Recall
NHF, HFA and Hemophilia Alliance Continue Push for Information on…
Medical
New MASAC Recommendations Focus on Offsite Hemostasis Screening and Treatment
New MASAC Recommendations Focus on Offsite Hemostasis Screening and…
Industry
BioMarin’s New Clinical Study to Focus on Antibody Development to AAVs
BioMarin’s New Clinical Study to Focus on Antibody Development to AAVs
Industry
Mylan Initiates Voluntary Nationwide Recall of Four Lots of Tranexamic Acid Injection, USP Due to Carton Label Mix-Up
Mylan Initiates Voluntary…
Medical Advisory
Medical Advisory
Medical Advisory #428: Mylan recalls Amiodarone, Tranexemaic Acid Injection…
Join NHF to Talk About Your Future
Join NHF to Talk About Your Future
NHF Receives Five-Year CDC Grant for Education Programs
NHF Receives Five-Year CDC Grant for Education Programs